查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1455673

裂谷熱疫苗市場，按產品類型、按應用、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Rift Valley Fever Vaccines Market, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年，裂谷熱疫苗市場規模為 2.1045 億美元，2024年至2032年複合CAGR為 6.2%。

裂谷熱疫苗市場-市場動態

透過公共衛生教育以及社會和醫療環境的進步提高意識，以推動市場需求

由於公共衛生教育的提高以及社會和醫療環境的進步，裂谷熱疫苗市場經歷顯著成長。技術進步使衛生和動物專業人員能夠有效地為人類和動物接種疫苗，進一步推動市場擴張。裂谷熱疫苗的促進因素包括裂谷熱疫情的日益流行，特別是在流行地區，這加劇了採取有效預防措施的迫切性。此外，政府、醫療機構和農業部門對裂谷熱對經濟和公共衛生影響的認知不斷提高，凸顯了疫苗接種作為疾病控制的主動方法的重要性。此外，疫苗技術和研究的進步，加上產業利益相關者和監管機構之間的合作努力，有助於裂谷熱疫苗的開發和可及性。這些促進因素共同強調了疫苗接種在緩解裂谷熱傳播並降低相關發病率和死亡率方面的關鍵作用。然而，儘管有這些積極因素，但對潛在不良反應的擔憂可能會阻礙市場成長。

裂谷熱疫苗市場 - 主要見解

根據研究分析師的分析，預計全球市場在預測期內（2024-2032年）每年將以 6.2%左右的CAGR成長

根據產品類型細分，預計活疫苗將在2023年佔據最大市場佔有率

從應用細分來看，2023年牛是主導類型

依地區分類，北美是2023年的主要收入來源

裂谷熱疫苗市場-細分分析：

全球裂谷熱疫苗市場根據產品類型、應用和地區進行細分。

根據產品類型，市場分為兩類：去活化和活疫苗。在裂谷熱疫苗市場中，活疫苗由於能夠引發強烈而持久的免疫反應，因此在該類型細分市場中佔據主導地位。這些疫苗含有裂谷熱病毒的弱化或減毒版本，反映了自然感染而不誘發疾病。這會引發強烈的免疫反應，產生抗體和記憶細胞，提供對未來感染的保護。活疫苗因其功效和賦予各種動物物種和種群廣泛免疫力的潛力而受到重視，使其成為裂谷熱疫苗接種計劃的首選。

市場依應用分為五類：牛、山羊、人、綿羊和其他。在應用方面，到2023年，牛隻將成為裂谷熱疫苗市場的主導部門。牛極易感染裂谷熱病毒，牲畜之間的疫情爆發可能會對農民和農業部門帶來重大的經濟影響。為牛接種裂谷熱疫苗有助於防止疾病傳播、降低發病率和死亡率並保障農民的生計。此外，保護牛隻免受裂谷熱的侵害對於維護糧食安全和避免人畜共患病傳播給人類非常重要，這突顯了針對這一關鍵動物群體的疫苗接種工作的重要性。

裂谷熱疫苗市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

裂谷熱疫苗市場-競爭格局：

在裂谷熱疫苗市場，該公司實施多種策略，以推動有效且易於使用的疫苗的開發。這些策略包括持續研究，目的是增強疫苗配方、改善給藥方案和提高疫苗穩定性，以方便儲存和運輸，特別是在資源有限的環境中。此外，公司與政府、國際組織和研究機構合作，以簡化疫苗開發、監管批准和分銷流程。此外，進行教育活動，以提高農民、獸醫和醫護人員對疫苗接種在控制裂谷熱疫情和保護動物和人類健康方面重要性的認知。

最近的發展：

2023年 4月，報告了一項重大進展：啟動了一項 1 期臨床試驗，評估 ChAdOx1 疫苗在英國成人中治療裂谷熱的安全性。這項非隨機開放標籤試驗是對抗裂谷熱旅程中的一個重要里程碑，並強調了開發針對這種病毒性疾病的有效疫苗的持續努力。

目錄

第1章 裂谷熱疫苗市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘要
    • 依產品類型分類的裂谷熱疫苗市場摘要
    • 依應用分類的裂谷熱疫苗市場摘要
    • 依國家分類的裂谷熱疫苗市場摘要
    • 依地區分類的裂谷熱疫苗市場摘要
  • 競爭洞察

第3章 裂谷熱疫苗主要市場趨勢

  • 裂谷熱疫苗市場促進因素
    • 市場促進因素的影響分析
  • 裂谷熱疫苗市場限制
    • 市場限制影響分析
  • 裂谷熱疫苗市場機會
  • 裂谷熱疫苗市場未來趨勢

第4章 裂谷熱疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 裂谷熱疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 裂谷熱疫苗市場格局

  • 2023年裂谷熱疫苗市佔率分析
  • 按主要製造商分類的故障資料
    • 既有參與者分析
    • 新興參與者分析

第7章 裂谷熱疫苗市場 - 依產品類型

  • 概述
    • 依產品類型分類的細分市場佔有率分析
    • 去活化
    • 活疫苗

第8章 裂谷熱疫苗市場 -依應用

  • 概述
    • 依應用的細分市場佔有率分析
    • 牛
    • 山羊
    • 人
    • 羊
    • 其他

第9章 裂谷熱疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美裂谷熱疫苗主要製造商
    • 北美市場規模和預測（依國家）
    • 北美市場規模和預測（依產品類型）
    • 北美市場規模和預測（依應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲裂谷熱疫苗主要製造商
    • 歐洲市場規模和預測（依國家）
    • 歐洲市場規模和預測（依產品類型）
    • 歐洲市場規模和預測（依應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區（APAC）
    • 概述
    • 亞太地區裂谷熱疫苗主要製造商
    • 亞太地區市場規模與預測（依國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（依應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲裂谷熱疫苗主要製造商
    • 拉丁美洲市場規模與預測（依國家）
    • 拉丁美洲市場規模與預測（依產品類型）
    • 拉丁美洲市場規模與預測（依應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲裂谷熱疫苗主要製造商
    • 中東和非洲市場規模及預測（依國家）
    • 中東和非洲市場規模及預測（依產品類型）
    • 中東和非洲市場規模及預測（依應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA的其他地區

第10章 主要供應商分析 - 裂谷熱疫苗產業

  • 競爭儀表板
  • 公司簡介
    • Veterinary Serum and Vaccine Research Institute
    • Medgene Labs
    • VSVRI
    • Onderstepoort Biological Products
    • OBP
    • Others

第11章 360 度分析師視角

第12章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2336

REPORT HIGHLIGHT

Rift Valley Fever Vaccines Market size was valued at USD 210.45 Million in 2023, expanding at a CAGR of 6.2% from 2024 to 2032.

Rift Valley Fever is a viral illness transmitted through mosquito bites, affecting both humans and animals. The virus spreads through direct contact with infected animal blood and tissues, as well as mosquito bites. While the virus often presents without symptoms, it can lead to serious complications such as encephalitis, blindness, and hemorrhagic fever. Rift Valley Fever vaccines come in two forms: live attenuated RVF vaccine (Smithburn strain) and killed vaccine. Vaccination protects both humans and animals, crucial for food security and economic stability. These vaccines are essential in preventing the spread of this zoonotic disease, playing a significant role in livestock management and public health initiatives, particularly in endemic areas where RVF outbreaks pose substantial risks.

Rift Valley Fever Vaccines Market- Market Dynamics

Increasing awareness through public health education and advancements in social and medical landscapes to propel market demand

The Rift Valley Fever Vaccines Market is experiencing significant growth due to heightened awareness through public health education and advancements in social and medical landscapes. Technological progress enables health and animal professionals to efficiently vaccinate both humans and animals, further driving market expansion. The drivers of Rift Valley Fever vaccines include the increasing prevalence of Rift Valley Fever outbreaks, particularly in endemic regions, which heightens the urgency for effective preventive measures. Additionally, the rising awareness among governments, healthcare organizations, and agricultural sectors about the economic and public health impacts of Rift Valley Fever underscores the importance of vaccination as a proactive approach to disease control. Furthermore, advancements in vaccine technology and research, coupled with collaborative efforts between industry stakeholders and regulatory bodies, contribute to the development and accessibility of Rift Valley Fever vaccines. These drivers collectively emphasize the critical role of vaccination in mitigating the spread of Rift Valley Fever and reducing its associated morbidity and mortality rates. However, concerns regarding potential adverse reactions may impede market growth despite these positive factors.

Rift Valley Fever Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.2% over the forecast period (2024-2032)

Based on product type segmentation, Live vaccines was predicted to show maximum market share in the year 2023

Based on Application segmentation, Cattle was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Rift Valley Fever Vaccines Market- Segmentation Analysis:

The Global Rift Valley Fever Vaccines Market is segmented on the basis of Product Type, Application, and Region.

The market is divided into two categories based on product type: Inactivated and Live. Within the Rift Valley Fever vaccine market, live vaccines take precedence in the type segment due to their capacity to elicit robust and enduring immune responses. These vaccines contain weakened or attenuated versions of the Rift Valley Fever virus, mirroring natural infection without inducing illness. This prompts a vigorous immune reaction, generating antibodies and memory cells that confer protection against future infections. Live vaccines are valued for their efficacy and potential to confer broad immunity across various animal species and populations, making them the preferred option for Rift Valley Fever vaccination initiatives.

The market is divided into five categories based on Application: Cattle, Goats, People, Sheep and Other. Regarding application, in 2023, the cattle segment emerges as the dominant sector in the Rift Valley Fever vaccine market. Cattle are highly vulnerable to Rift Valley Fever virus infection, and outbreaks among livestock can carry significant economic repercussions for farmers and the agricultural sector. Vaccinating cattle against Rift Valley Fever helps prevent disease spread, diminish morbidity and mortality rates, and safeguard farmers' livelihoods. Additionally, shielding cattle from Rift Valley Fever is crucial for upholding food security and averting zoonotic transmission to humans, highlighting the significance of vaccination endeavors targeting this pivotal animal demographic.

Rift Valley Fever Vaccines Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Rift Valley Fever Vaccines Market- Competitive Landscape:

In the Rift Valley Fever vaccine market, companies are implementing diverse strategies to advance the development of effective and accessible vaccines. These strategies encompass continuous research aimed at enhancing vaccine formulations, refining dosing regimens, and improving vaccine stability to facilitate easier storage and transportation, particularly in resource-constrained environments. Moreover, companies are engaging in collaborations with governments, international organizations, and research institutions to streamline vaccine development, regulatory approval, and distribution processes. Additionally, educational campaigns are being conducted to raise awareness among farmers, veterinarians, and healthcare workers regarding the importance of vaccination in controlling Rift Valley Fever outbreaks and protecting both animal and human health.

Recent Developments:

In April 2023, a significant development was reported: the initiation of a phase 1 clinical trial assessing the safety of a ChAdOx1 vaccine regarding Rift Valley Fever in UK adults. This non-randomized open-label, trial represents a critical milestone in the journey toward combating Rift Valley Fever and underscores the ongoing efforts to develop effective vaccines against this viral illness.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RIFT VALLEY FEVER VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Veterinary Serum and Vaccine Research Institute

Medgene Labs

VSVRI

Onderstepoort Biological Products

OBP

Others

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Inactivated
  • Live

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Cattle
  • Goats
  • People
  • Sheep
  • Other

GLOBAL RIFT VALLEY FEVER VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Rift Valley Fever Vaccines Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Rift Valley Fever Vaccines Market Snippet by Product Type
    • 2.1.2.Rift Valley Fever Vaccines Market Snippet by Application
    • 2.1.3.Rift Valley Fever Vaccines Market Snippet by Country
    • 2.1.4.Rift Valley Fever Vaccines Market Snippet by Region
  • 2.2.Competitive Insights

3.Rift Valley Fever Vaccines Key Market Trends

  • 3.1.Rift Valley Fever Vaccines Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Rift Valley Fever Vaccines Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Rift Valley Fever Vaccines Market Opportunities
  • 3.4.Rift Valley Fever Vaccines Market Future Trends

4.Rift Valley Fever Vaccines Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Rift Valley Fever Vaccines Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Rift Valley Fever Vaccines Market Landscape

  • 6.1.Rift Valley Fever Vaccines Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Rift Valley Fever Vaccines Market - By Product Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2.Inactivated
    • 7.1.3.Live

8.Rift Valley Fever Vaccines Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Cattle
    • 8.1.3.Goats
    • 8.1.4.People
    • 8.1.5.Sheep
    • 8.1.6.Other

9.Rift Valley Fever Vaccines Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Rift Valley Fever Vaccines Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Rift Valley Fever Vaccines Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Rift Valley Fever Vaccines Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Rift Valley Fever Vaccines Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Rift Valley Fever Vaccines Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Rift Valley Fever Vaccines Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Veterinary Serum and Vaccine Research Institute
    • 10.2.2.Medgene Labs
    • 10.2.3.VSVRI
    • 10.2.4.Onderstepoort Biological Products
    • 10.2.5.OBP
    • 10.2.6.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Rift Valley Fever Vaccines Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Rift Valley Fever Vaccines Market, by Product Type 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Rift Valley Fever Vaccines Market, by Application 2019-2032 (USD Million)
  • TABLE Rift Valley Fever Vaccines Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Rift Valley Fever Vaccines Market, by Region 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE North America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Europe Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Latin America Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Product Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Rift Valley Fever Vaccines Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Rift Valley Fever Vaccines Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Product Type segment market share analysis, 2023 & 2032
  • FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Europe Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Latin America Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Germany Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE India Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Brazil Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Rift Valley Fever Vaccines Market share analysis by country, 2023
  • FIGURE Saudi Arabia Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Rift Valley Fever Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)